Written by : Dr. Aishwarya Sarthe
April 18, 2025
The investment will enable SRV to expand its multispecialty, critical care-focused hospital network and strengthen its consultant-led care model.
SRV Hospitals has raised INR 140 crore from InvAscent, a life sciences-focused private equity fund.
The investment will enable SRV to expand its multispecialty, critical care-focused hospital network and strengthen its consultant-led care model.
Established in 2015, SRV operates five tertiary care hospitals across Mumbai, Nashik, and Bengaluru, with a combined capacity of over 500 beds. The group’s healthcare model is centred on advanced critical and surgical care, supported by structured clinical protocols and outcome-based systems.
According to the company, the funding will be used to scale operations, invest in technology, and enhance clinician support systems. SRV stated that the capital positions the group for its next phase of growth while deepening its focus on accessible tertiary care.
The group has positioned itself as a high-acuity neighbourhood healthcare provider, emphasizing clinical outcomes and patient experience. The company did not disclose specific timelines for expansion or technology deployment.
InvAscent, the investor in this round, has previously backed healthcare providers including HCG Hospitals and Dr. Agarwal’s Eye Hospital.
The fund brings sectoral knowledge in addition to financial capital and is expected to support SRV’s operational and strategic plans